A new experimental brain implantation device, Blindsight, designed to restore vision has been awarded the US Food and Drug Administration’s (FDA) ‘breakthrough device’ designation.
The device was created by Elon Musk’s brain chip company, Neuralink, which specialises in developing a brain-chip interface that can be implanted within the skull.
Blindsight is designed to allow individuals who have lost both eyes and optic nerves to regain sight.
On Tuesday, in a post made on X announcing the new development, Mr Musk said Blindsight can help blind people regain their sight as long as their visual cortex is still intact.
He said, “The Blindsight device from Neuralink will enable even those who have lost both eyes and their optic nerve to see.
Subscribe our newsletter to stay updated
Thank you for subscribing!
Subscribe our newsletter to stay updated
Thank you for subscribing!
